Lilly Data Show Zepbound Reduces Type 2 Diabetes Risk Long Term

 
• By Joseph Haas
  
Preventive medicine
Lilly reports data showing a diabetes prevention benefit with tirzepatide • Source: Shutterstock
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D